CPT code 88188 denotes the clinical interpretation of flow cytometry studies that include nine to 15 markers, typically performed by a pathologist or clinical laboratory physician. This code captures the professional interpretive component of multiparameter flow cytometry used in hematopathology and immunophenotyping, and is nationally relevant given the central role of flow cytometry in diagnosing hematologic malignancies, immune disorders, and monitoring therapy.

Key payers examined include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and coding scope, payer coverage considerations, and benchmarking insights where available. The publication outlines common billing practices for interpretation-only services, the typical clinical settings where 88188 is reported, and how this code fits within laboratory and pathology service lines.

The analysis provides national-level context rather than state-specific guidance. Where input data was not provided, the report notes the absence of payer-specific policy details, associated taxonomies, diagnoses, and related codes. The content is designed to inform coding professionals, laboratory administrators, and policy analysts about the clinical purpose, typical use cases, and payer landscape relevant to CPT code 88188.